Comparable stake leader
OXFORD FINANCE LLC
SEC ownership of KALA BIO, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001479419.
Disclosed value leader
Rajeev M. Shah
Comparable rows
32/50
Latest evidence
20 May 2026
- Public ticker
- KALA on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
OXFORD FINANCE LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
32 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
OXFORD FINANCE LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
20 May 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001479419
- Issuer location
- Arlington, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of KALA BIO, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
OXFORD FINANCE LLC
Disclosed value leader
Rajeev M. Shah
Comparable rows
32/50
Latest evidence
20 May 2026
3/4/5
13D/G
13F
Lead comparable stake: 16%
18 rows are not safely comparable across share classes.
13D/G row: OXFORD FINANCE LLC
Showing 1-8 of 50 holder rows.
Quick read
OXFORD FINANCE LLC leads the comparable SEC ownership view at 16%.
32 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens OXFORD FINANCE LLC's linked filing trail.
Comparable ownership
Top 5
OXFORD FINANCE LLC
16%
LIFESCI CAPITAL, LLC
7.9%
ADAR1 Capital Management, LLC
4.9%
SR ONE CAPITAL MANAGEMENT, LLC
4.6%
David E. Lazar
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| OXFORD FINANCE LLC |
3/4/5
13D/G
10%+ Owner
|
16%
from 13D/G
|
$1,215,000
1,620,000 shares
|
— | 25 Nov 2025 |
| LIFESCI CAPITAL, LLC |
13D/G
|
7.9%
|
$1,274,240
2,200,000 shares
|
$0 | 30 Dec 2025 |
| ADAR1 Capital Management, LLC |
13D/G
13F
Company
|
4.9%
|
$1,270,559
298,955 shares
|
$0 | 31 Dec 2024 |
| SR ONE CAPITAL MANAGEMENT, LLC |
13D/G
|
4.6%
|
$5,255,568
344,176 shares
|
-$1,020,402 | 14 Oct 2025 |
| David E. Lazar |
13D/G
3/4/5
Lazar David E. · Chief Executive Officer, Director
|
3.9%
|
$1,719,376
719,404 shares
|
$0 | 20 May 2026 |
| BAKER BROS. ADVISORS LP |
3/4/5
13D/G
Former 10% owner
|
0.01%
from 13D/G
|
$588,123
425,006 shares
|
-$1,056,722 | 30 Sep 2025 |
| Point72 Asset Management, L.P. |
13D/G
|
0%
|
$393
257 shares
|
-$717,340 | 30 Sep 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.4%
|
$72,272
417,517 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$1,056,722.
Buys
$0
Insiders: 0
Sells
$1,056,722
Insiders: 1
Net
-$1,056,722
Shares: -730,408
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 730,408
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 730,408 | $0 | $1,056,722 | -$1,056,722 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 25 reporting-owner rows connected to KALA BIO, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
25
Largest Forms 3/4/5 holder
Rajeev M. Shah
Net 12M change
-$1,056,722
Latest report
30 Jan 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Rajeev M. Shah | Director | $73,564,492 | Mixed | 17 Jun 2021 | ||
| RA CAPITAL MANAGEMENT, L.P. | 10%+ Owner | $47,446,992 | Mixed | 26 May 2022 | ||
| Gregory Grunberg | Director | $36,745,536 | Mixed | 17 Jun 2021 | ||
| Hongming Chen | Chief Scientific Officer | $1,378,431 | Mixed | 26 Oct 2021 | ||
| OXFORD FINANCE LLC | 10%+ Owner | $1,215,000 | Mixed | 25 Nov 2025 | ||
| BAKER BROS. ADVISORS LP | Former 10% owner | $588,123 | -$1,056,722 | -64% | Filing P/S | 30 Sep 2025 |
| Eric Trachtenberg | Chief Legal Officer, Chief Compliance Officer and Secretary | $458,765 | Filing P/S | 04 Jan 2024 | ||
| Iwicki Mark T. | Director | $212,257 | Mixed | 23 Oct 2025 | ||
| Mark S. Blumenkranz | Director | $87,495 | Mixed | 11 Jun 2024 | ||
| Darius Kharabi | Chief Business Officer | $85,608 | Mixed | 22 Oct 2025 | ||
| Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | $73,701 | Mixed | 22 Oct 2025 | ||
| Todd Bazemore | Director | $73,662 | Mixed | 22 Oct 2025 | ||
| Andrew I. Koven | Director | $68,566 | Mixed | 15 Jun 2025 | ||
| Howard B. Rosen | Director | $66,667 | Mixed | 15 Jun 2025 | ||
| Mary Reumuth | Chief Financial Officer | $59,257 | Mixed | 22 Oct 2025 | ||
| Gregory D. Perry | Director | $53,909 | Mixed | 15 Jun 2025 | ||
| C. Daniel Myers | Director | $41,910 | Mixed | 15 Jun 2025 | ||
| Marjan Farid | Director | $41,377 | Mixed | 15 Jun 2025 | ||
| David E. Lazar | Chief Executive Officer, Director | $0 | Mixed | 18 Dec 2025 | ||
| Chaim D. Berger | Director | Mixed | 30 Jan 2026 |
Recent insider transactions for KALA BIO, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| David E. Lazar | KALA | Convertible Loan | Other | -100% | -368,614 | 0 | 18 Dec 2025 | Direct | ||
| David E. Lazar | KALA | Series AA Convertible Preferred Stock | Award | 900,000 | 900,000 | 24 Nov 2025 | Direct | |||
| Iwicki Mark T. | KALA | Common Stock | Sale | -59.9% | -154,894 | 103,540 | 23 Oct 2025 | Direct | ||
| Mary Reumuth | KALA | Common Stock | Sale | -3.24% | -967 | 28,906 | 23 Oct 2025 | Direct | ||
| Mary Reumuth | KALA | Common Stock | Sale | -51.9% | -32,230 | 29,873 | 22 Oct 2025 | Direct | ||
| Todd Bazemore | KALA | Common Stock | Sale | -57.1% | -47,768 | 35,932 | 22 Oct 2025 | Direct | ||
| Romulus K. Brazzell | KALA | Common Stock | Sale | -56.5% | -46,748 | 35,952 | 22 Oct 2025 | Direct | ||
| Darius Kharabi | KALA | Common Stock | Sale | -33.2% | -20,806 | 41,760 | 22 Oct 2025 | Direct | ||
| Baker Bros. Advisors Lp | KALA | Common Stock | Sale | -91.7% | $710,729 | $1.38 | -513,607 | 46,480 | 01 Oct 2025 | See Footnotes |
| Baker Bros. Advisors Lp | KALA | Common Stock | Sale | -69.1% | $345,993 | $1.60 | -216,801 | 97,120 | 30 Sep 2025 | See Footnotes |
| Todd Bazemore | KALA | Stock Option (right to buy) | Award | 180,000 | 180,000 | 29 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.